Business Description
Inogen Inc
NAICS : 325412
SIC : 3842
ISIN : US45780L1044
Share Class Description:
INGN: Ordinary SharesDescription
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.99 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.52 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.46 | |||||
| Beneish M-Score | -3.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1 | |||||
| 3-Year EPS without NRI Growth Rate | -97.5 | |||||
| 3-Year Book Growth Rate | -17.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 11.15 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.66 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.77 | |||||
| 9-Day RSI | 48.19 | |||||
| 14-Day RSI | 48.96 | |||||
| 3-1 Month Momentum % | -4.67 | |||||
| 6-1 Month Momentum % | 33.09 | |||||
| 12-1 Month Momentum % | 94.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.66 | |||||
| Quick Ratio | 2.34 | |||||
| Cash Ratio | 1.67 | |||||
| Days Inventory | 46.52 | |||||
| Days Sales Outstanding | 44.28 | |||||
| Days Payable | 29.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.2 | |||||
| Shareholder Yield % | 0.55 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.22 | |||||
| Operating Margin % | -18.13 | |||||
| Net Margin % | -15.89 | |||||
| FCF Margin % | -4.37 | |||||
| ROE % | -26.33 | |||||
| ROA % | -16.46 | |||||
| ROIC % | -37.04 | |||||
| 3-Year ROIIC % | 197.17 | |||||
| ROC (Joel Greenblatt) % | -75.2 | |||||
| ROCE % | -24.06 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.69 | |||||
| PB Ratio | 1.24 | |||||
| Price-to-Tangible-Book | 1.62 | |||||
| Price-to-Operating-Cash-Flow | 40.33 | |||||
| EV-to-EBIT | -2.15 | |||||
| EV-to-EBITDA | -3.31 | |||||
| EV-to-Revenue | 0.39 | |||||
| EV-to-FCF | -8.92 | |||||
| Price-to-GF-Value | 0.85 | |||||
| Price-to-Projected-FCF | 1.9 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 3.13 | |||||
| Earnings Yield (Greenblatt) % | -46.51 | |||||
| FCF Yield % | -6.3 | |||||
| Forward Rate of Return (Yacktman) % | -16.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 331.52 | ||
| EPS (TTM) ($) | -2.25 | ||
| Beta | 1.67 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.51 | ||
| Volatility % | 63.19 | ||
| 14-Day RSI | 48.96 | ||
| 14-Day ATR ($) | 0.433108 | ||
| 20-Day SMA ($) | 9.678 | ||
| 12-1 Month Momentum % | 94.01 | ||
| 52-Week Range ($) | 5.08 - 13.3299 | ||
| Shares Outstanding (Mil) | 23.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inogen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inogen Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inogen Inc Frequently Asked Questions
What is Inogen Inc(INGN)'s stock price today?
The current price of INGN is $9.41. The 52 week high of INGN is $13.33 and 52 week low is $5.08.
When is next earnings date of Inogen Inc(INGN)?
The next earnings date of Inogen Inc(INGN) is 2025-02-27 Est..
Does Inogen Inc(INGN) pay dividends? If so, how much?
Inogen Inc(INGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers